BRIGHTS DISEASE TODAY - PATHOGENESIS AND TREATMENT OF GLOMERULONEPHRITIS .3.

被引：21

作者：

CAMERON, JS

机构：

来源：

BMJ-BRITISH MEDICAL JOURNAL | 1972年 / 4卷 / 5834期

关键词：

D O I：

10.1136/bmj.4.5834.217

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：217 / +

页数：1

共 153 条

[1] ABRAMOWI.M, 1970, LANCET, V1, P959
[2] ALLISON AC, 1969, LANCET, V1, P1232
[3] ALLISON AC, 1971, LANCET, V2, P1401
[4] ARNEIL GC, 1961, LANCET, V2, P1103
[5] BACH JF, 1972, ACTUALITES NEPHROLOG, P73
[6] BALIAH T, 1972, P SOC EXP BIOL MED, V140, P329
[7] BEIRNE GL, AM SOCIETY NEPHROLOG, P8
[8] CONTROLLED TRIAL OF PREDNISONE IN ADULT PATIENTS WITH NEPHROTIC SYNDROME
BLACK, DAK
ROSE, G
BREWER, DB
[J]. BRITISH MEDICAL JOURNAL, 1970, 3 (5720) : 421 - &
[9] BLACK JA, 1965, LANCET, V2, P921
[10] ISOLATION OF A FRAGMENT (C3A) OF THIRD COMPONENT OF HUMAN COMPLEMENT CONTAINING ANAPHYLATOXIN AND CHEMOTACTIC ACTIVITY AND DESCRIPTION OF AN ANAPHYLATOXIN INACTIVATOR OF HUMAN SERUM
BOKISCH, VA
MULLEREB.HJ
COCHRANE, CG
[J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1969, 129 (05) : 1109 - &